Lenvima 4 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV683
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,547
Award facts
- Contract value 100% obligated
- $21,547.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,547.44 to AmerisourceBergen Drug Corp for the supply of LENVIMA 4 mg capsules (30-count packaging) on January 20, 2026, with completion expected by February 10, 2026. This firm fixed-price delivery order represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, with the product fulfillment occurring at the company's Conshohocken facility. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which maintains a significant indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, designed to support pharmaceutical supply requirements for military healthcare systems globally.
LENVIMA is an oncology therapeutic agent, reflecting the company's established portfolio of specialty medications supplied to military treatment facilities and federal healthcare programs. The delivery order structure allows DLA to procure specific pharmaceutical products efficiently under pre-established pricing and terms negotiated through the parent indefinite delivery vehicle. This award demonstrates the ongoing utilization of AmerisourceBergen's comprehensive pharmaceutical distribution capabilities to meet Department of Defense medical supply requirements for specialty cancer treatments and other critical medications essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV683?
SPE2DR26FV683 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FV683 worth?
The government has obligated $21,547 on SPE2DR26FV683.
Is contract SPE2DR26FV683 an order under another contract?
Yes. SPE2DR26FV683 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV683 competed?
The extent of competition for SPE2DR26FV683 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award